Detalhe da pesquisa
1.
Validation and Performance of FibroScan®-AST (FAST) Score on a Brazilian Population with Nonalcoholic Fatty Liver Disease.
Dig Dis Sci
; 67(11): 5272-5279, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35091842
2.
Evaluation of thrombocytopenia in patients with non-alcoholic fatty liver disease without cirrhosis.
Ann Hepatol
; 19(1): 88-91, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31575467
3.
Transient hepatic elastography has the best performance to evaluate liver fibrosis in non-alcoholic fatty liver disease (NAFLD).
Ann Hepatol
; 18(3): 445-449, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31031166
4.
Relationship of ferritin and hepcidin with disease severity in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus.
Liver Int
; 43(11): 2571-2575, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37752888
5.
The performance of M and XL probes of FibroScan for the diagnosis of steatosis and fibrosis on a Brazilian nonalcoholic fatty liver disease cohort.
Eur J Gastroenterol Hepatol
; 32(2): 231-238, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31464788